Terumo BCT and PwC Belgium Collaborate on Therapy Access

Terumo Blood and Cell Technologies (Terumo BCT) and PwC Belgium have partnered to improve access to advanced cell and gene therapies in Europe. This joint effort seeks to address existing barriers that prevent patients from receiving cutting-edge medical treatments. The partnership will kick off with an event in Brussels on Dec. 11, 2025, where industry…

This Article Is Locked, But Not Out of Reach

Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.

Create My Free Account

Curious how it works? Watch the Quickstart

Want everything unlocked? See Paid Options

Already a member? Log in here